Abbvie Inc
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - General
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio.
Did you know?
Generated $14.7 in free cash flow for every $1 of capital expenditure in FY25.
Current Price
$208.84
-2.86%GoodMoat Value
$131.68
36.9% overvaluedProfile
Valuation (TTM)
Market Cap$369.10B
P/E87.34
EV$424.43B
P/B—
Shares Out1.77B
P/Sales6.04
Revenue$61.16B
EV/EBITDA24.85
Abbvie Inc (ABBV) Stock News
ABBV Stock News & Headlines
Latest stock news and headlines for Abbvie Inc (ABBV). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $208.84. Market cap: $369.10B. Sector: Healthcare. Industry: Drug Manufacturers - General. This page aggregates the latest news articles relevant to ABBV from financial news sources, helping investors stay current on events that may impact Abbvie Inc's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Abbvie Inc (ABBV).